Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
82356162 | 8235616 | 2 | F | 20111012 | 20121029 | 20111108 | 20121029 | EXP | PHHY2011DK097164 | NOVARTIS | 70.51 | YR | F | Y | 0.00000 | 20121029 | MD | DK | DK |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
82356162 | 8235616 | 1 | PS | ACLASTA | 1 | INTRAVENOUS | 5 MG/ 100 ML, YEARLY | U | 21817 | 5 | MG | Solution For Injection |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
82356162 | 8235616 | 1 | Osteoporosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
82356162 | 8235616 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
82356162 | 8235616 | Azotaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
82356162 | 8235616 | 1 | 20110909 | 0 |